Halozyme
HALO
121 hedge funds and large institutions have $810M invested in Halozyme in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 23 closing their positions.
26% more call options, than puts
Call options by funds: $13.2M | Put options by funds: $10.5M
25% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 36
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less capital invested
Capital invested by funds: $857M → $810M (-$46.8M)
5% less funds holding
Funds holding: 128 → 121 (-7)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$9.52M |
| 2 |
First Eagle Investment Management
New York
|
+$8.05M |
| 3 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$7M |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$5.56M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$9.82M |
| 2 |
QF
QVT Financial
New York
|
-$4.77M |
| 3 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$4.21M |
| 4 |
Renaissance Technologies
New York
|
-$2.86M |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$2M |
HALO Hedge Fund Activity: Q3 2014 in Review
121 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2014, worth a combined $810M — down 5.5% from $857M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of HALO and 16 opened new positions — a net loss of 7 holders — while 36 trimmed existing stakes and 45 added.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $9.52M. The largest seller was Norges Bank, cutting an estimated $9.82M.
- 121 institutional investors held Halozyme (HALO) as of Q3 2014, down from 128 in Q2 2014.
- Funds reported $810M of Halozyme stock for Q3 2014, down 5.5% quarter-over-quarter.
- 16 funds opened new Halozyme positions in Q3 2014 and 23 closed out, a net change of -7 holders.
- The largest Halozyme buyer in Q3 2014 was OppenheimerFunds, an estimated $9.52M added.
- The largest Halozyme seller in Q3 2014 was Norges Bank, an estimated $9.82M sold.
Based on aggregated 13F filings for Q3 2014.